Managing the Pre- and Post-analytical Phases of the Total Testing Process

被引:137
作者
Hawkins, Robert [1 ]
机构
[1] Tan Tock Seng Hosp, Dept Lab Med, Tan Tock Seng 308433, Singapore
关键词
Specimen handling; Laboratories; Quality assurance; Healthcare; Diagnostic errors; Risk management; PATHOLOGISTS Q-PROBES; LABORATORY CRITICAL-VALUES; QUALITY INDICATORS; CLINICAL LABORATORIES; IDENTIFICATION ERRORS; TRANSFUSION ERRORS; MEDICAL ERRORS; ADVERSE EVENTS; PATIENT SAFETY; HOSPITALIZED-PATIENTS;
D O I
10.3343/alm.2012.32.1.5
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
For many years, the clinical laboratory's focus on analytical quality has resulted in an error rate of 4-5 sigma, which surpasses most other areas in healthcare. However, greater appreciation of the prevalence of errors in the pre-and post-analytical phases and their potential for patient harm has led to increasing requirements for laboratories to take greater responsibility for activities outside their immediate control. Accreditation bodies such as the Joint Commission International (JCI) and the College of American Pathologists (CAP) now require clear and effective procedures for patient/sample identification and communication of critical results. There are a variety of free on-line resources available to aid in managing the extra-analytical phase and the recent publication of quality indicators and proposed performance levels by the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) working group on laboratory errors and patient safety provides particularly useful benchmarking data. Managing the extra-laboratory phase of the total testing cycle is the next challenge for laboratory medicine. By building on its existing quality management expertise, quantitative scientific background and familiarity with information technology, the clinical laboratory is well suited to play a greater role in reducing errors and improving patient safety outside the confines of the laboratory.
引用
收藏
页码:5 / 16
页数:12
相关论文
共 99 条
[71]   Assessment of critical values policies in Italian institutions: comparison with the US situation [J].
Piva, Elisa ;
Sciacovelli, Laura ;
Laposata, Michael ;
Plebani, Mario .
CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2010, 48 (04) :461-468
[72]   Evaluation of Effectiveness of a Computerized Notification System for Reporting Critical Values [J].
Piva, Elisa ;
Sciacovelli, Laura ;
Zaninotto, Martina ;
Laposata, Michael ;
Plebani, Mario .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2009, 131 (03) :432-441
[73]   Laboratory network of excellence: enhancing patient safety and service effectiveness [J].
Plebani, M ;
Ceriotti, F ;
Messeri, G ;
Ottomano, C ;
Pansini, N ;
Bonini, P .
CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2006, 44 (02) :150-160
[75]  
Plebani M, 1997, CLIN CHEM, V43, P1348
[76]   Errors in clinical laboratories or errors in laboratory medicine? [J].
Plebani, Mario .
CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2006, 44 (06) :750-759
[77]   Quality indicators for laboratory diagnostics: consensus is needed [J].
Plebani, Mario ;
Sciacovelli, Laura ;
Lippi, Giuseppe .
ANNALS OF CLINICAL BIOCHEMISTRY, 2011, 48 :479-479
[78]   The detection and prevention of errors in laboratory medicine [J].
Plebani, Mario .
ANNALS OF CLINICAL BIOCHEMISTRY, 2010, 47 :101-110
[79]   Exploring the iceberg of errors in laboratory medicine [J].
Plebani, Mario .
CLINICA CHIMICA ACTA, 2009, 404 (01) :16-23
[80]   Cost consequences of implementing an electronic decision support system for ordering laboratory tests in primary care:: Evidence from a controlled prospective study in the Netherlands [J].
Poley, Marten J. ;
Edelenbos, Kyra I. ;
Mosseveld, Mees ;
van Wijk, Marc A. M. ;
de Bakker, Dinny H. ;
van der Lei, Johan ;
Rutten-van Molken, Maureen P. M. H. .
CLINICAL CHEMISTRY, 2007, 53 (02) :213-219